Tissue Sealants - Medical Devices Pipeline Assessment, 2016

Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 11
2.1 Tissue Sealants Overview 11
3 Products under Development 12
3.1 Tissue Sealants - Pipeline Products by Stage of Development 12
3.2 Tissue Sealants - Pipeline Products by Segment 13
3.3 Tissue Sealants - Pipeline Products by Territory 14
3.4 Tissue Sealants - Pipeline Products by Regulatory Path 15
3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date 16
3.6 Tissue Sealants - Ongoing Clinical Trials 17
4 Tissue Sealants - Pipeline Products under Development by Companies 18
4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development 18
4.2 Tissue Sealants - Pipeline Products by Stage of Development 20
5 Tissue Sealants Companies and Product Overview 22
5.1 Advanced Medical Solutions Group plc Company Overview 22
5.1.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 22
5.2 Argon Medical Devices Inc. Company Overview 24
5.2.1 Argon Medical Devices Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.3 Baxter International Inc Company Overview 25
5.3.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Biomedica Management Corp Company Overview 27
5.4.1 Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Boston University Company Overview 28
5.5.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 C. R. Bard Inc Company Overview 29
5.6.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Calmare Therapeutics Inc Company Overview 33
5.7.1 Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.8 Clemson University Company Overview 35
5.8.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 Cohera Medical, Inc. Company Overview 36
5.9.1 Cohera Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Covalent Medical, Inc. (Inactive) Company Overview 41
5.10.1 Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41
5.11 DSM Biomedical B.V. Company Overview 42
5.11.1 DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 42
5.12 Emory University Company Overview 43
5.12.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 43
5.13 Ethicon Endo-Surgery, Inc. Company Overview 44
5.13.1 Ethicon Endo-Surgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.14 Gamma Therapeutics Inc Company Overview 45
5.14.1 Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
5.15 Gecko Biomedical Company Overview 46
5.15.1 Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview 46
5.16 Grifols SA Company Overview 47
5.16.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 47
5.17 Hemostasis, LLC Company Overview 49
5.17.1 Hemostasis, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 HyperBranch Medical Technology, Inc. Company Overview 51
5.18.1 HyperBranch Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.19 InVivo Therapeutics Corporation Company Overview 53
5.19.1 InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview 53
5.20 John Hopkins University Company Overview 54
5.20.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 54
5.21 Kollodis BioSciences, Inc. Company Overview 55
5.21.1 Kollodis BioSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.22 Kuros Biosciences AG Company Overview 56
5.22.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 56
5.23 LifeBond Ltd. Company Overview 58
5.23.1 LifeBond Ltd. Pipeline Products & Ongoing Clinical Trials Overview 58
5.24 Medical Adhesive Revolution GmbH Company Overview 62
5.24.1 Medical Adhesive Revolution GmbH Pipeline Products & Ongoing Clinical Trials Overview 62
5.25 Medisse BV Company Overview 64
5.25.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 64
5.26 OptMed, Inc. Company Overview 65
5.26.1 OptMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.27 Pharming Group NV Company Overview 68
5.27.1 Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview 68
5.28 Polyganics B.V. Company Overview 70
5.28.1 Polyganics B.V. Pipeline Products & Ongoing Clinical Trials Overview 70
5.29 Protein Polymer Technologies Inc (Inactive) Company Overview 74
5.29.1 Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74
5.30 Sea Run Holdings Inc Company Overview 75
5.30.1 Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 75
5.31 Sealantis Ltd. Company Overview 76
5.31.1 Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76
5.32 Shanghai Haohai Biological Technology Co., Ltd. Company Overview 81
5.32.1 Shanghai Haohai Biological Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
5.33 Surgical Sealants, Inc. Company Overview 83
5.33.1 Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.34 Teijin Pharma Ltd Company Overview 84
5.34.1 Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 84
5.35 Texas A&M University Company Overview 86
5.35.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 86
5.36 The Medicines Company Company Overview 88
5.36.1 The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview 88
5.37 University of Akron Company Overview 90
5.37.1 University of Akron Pipeline Products & Ongoing Clinical Trials Overview 90
6 Tissue Sealants- Recent Developments 91
6.1 Nov 17, 2016: Cesca Therapeutics Reports First Quarter Fiscal 2017 Results and Provides Business Update 91
6.2 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 91
6.3 Nov 08, 2016: Sales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million 92
6.4 Nov 04, 2016: InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update 96
6.5 Nov 03, 2016: DSM Q3 2016 Results 97
6.6 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 99
6.7 Oct 26, 2016: The Medicines Company Reports Third-Quarter 2016 Financial Results 99
6.8 Oct 25, 2016: EVARREST Fibrin Sealant Patch Gains FDA Approval On Expanded Indication For General Hemostasis 101
6.9 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 102
6.10 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 103
6.11 Oct 25, 2016: Bard Announces Third Quarter Results 103
6.12 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 104
6.13 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs 105
6.14 Sep 20, 2016: Cesca Therapeutics Reports Fourth Quarter and Fiscal 2016 Year End Results 106
6.15 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 107
6.16 Sep 14, 2016: Advanced Medical Solutions Group: Interim Results for the six months ended 30 June 2016 107
6.17 Sep 13, 2016: Pfizer Enters into Distribution Agreement Adhezion Biomedical 115
6.18 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 115
6.19 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 115
6.20 Aug 11, 2016: InVivo Therapeutics Appoints Pamela Stahl as Chief Commercial Officer 118
6.21 Aug 04, 2016: InVivo Therapeutics Reports 2016 Second Quarter Financial Results and Business Update 119
6.22 Aug 03, 2016: Cesca Therapeutics Prices Private Placement of Shares for USD2.5 Million 120
6.23 Jul 28, 2016: Sales of the Bioscience Division grow by +7.0%, increasing Grifols' revenues by +2.7% to EUR 1,952 million 120
6.24 Jul 27, 2016: The Medicines Company Reports Second-Quarter 2016 Business and Financial Results 126
6.25 Jul 26, 2016: Bard Announces Second Quarter Results 129
6.26 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 129
6.27 Jul 25, 2016: CryoLife Reports Second Quarter 2016 Financial Results 131
6.28 Jul 21, 2016: LifeBond Receives FDA IDE Approval For LifeSeal GI Surgical Sealant Clinical Trial 132
6.29 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 132
6.30 Jul 12, 2016: Cohera Medical Receives FDA Approval to Begin Clinical Trials of its Sylys Surgical Sealant in the U.S. 134
6.31 Jul 12, 2016: McShane Construction Company Marks Significant Progress at New 630,000 S.F. Medical Supplies Distribution Center in Phoenix, Arizona 135
6.32 Jul 08, 2016: Reed Construction Selected To Complete New Medline Headquarters 135
6.33 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 135
6.34 Jun 27, 2016: Medline and Medic Management Group Launch New GPO Distribution Partnership 136
6.35 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 136
6.36 Jun 21, 2016: MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims 137
6.37 Jun 20, 2016: Cesca Therapeutics Appoints Mark Bagnall to Its Board of Directors 137
6.38 Jun 16, 2016: Grifols confirms that it has voluntarily signed the EFPIA Code of Conduct 138
6.39 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 138
6.40 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 139
6.41 May 23, 2016: Tissuemed announces TissuePatch approval in China 141
6.42 May 23, 2016: Calmare Therapeutics Uplists 142
6.43 May 23, 2016: New Distribution Partnership for Edward-Elmhurst Health’s Physician Offices Results in Cost Savings of 10 Percent 142
6.44 May 20, 2016: Surgical Specialties Announces Approval of Expanded Use for BioSentry Track Sealant System in Europe 142
6.45 May 19, 2016: Calmare Therapeutics Reports First Quarter 2016 Results 143
6.46 May 19, 2016: Medline Inks Three-Year Prime Vendor Distribution Agreement with SBH Health System 144
6.47 May 16, 2016: The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer 144
6.48 May 12, 2016: Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results and Provides Business Update 145
6.49 May 09, 2016: The Medicines Company Reports First-Quarter 2016 Business and Financial Results 146
6.50 May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 147
6.51 Apr 27, 2016: European Commission Approves Surgical Patch TachoSil (human thrombin/human fibrogen) for Use in Neurological Surgery 147
6.52 Apr 17, 2016: LifeBond Secures CE Marking for LifeSeal Surgical Sealant for GI Procedures 148
6.53 Mar 17, 2016: Gecko Biomedical Raises USD25 Million in Series A2 Financing 149
6.54 Mar 05, 2016: New Data Released on EVARREST Fibrin Sealant Patch as a Hemostatic Adjunct in Aortic Reconstruction Surgery 149
6.55 Jan 12, 2016: OptMed obtains FDA 510(k) marketing clearance for topical skin adhesive 150
7 Appendix 152
7.1 Methodology 152
7.2 About GlobalData 155
7.3 Contact Us 155
7.4 Disclaimer 155

List Of Tables
1.1 List of Tables
Table 1: Tissue Sealants - Pipeline Products by Stage of Development 12
Table 2: Tissue Sealants - Pipeline Products by Segment 13
Table 3: Tissue Sealants - Pipeline Products by Territory 14
Table 4: Tissue Sealants - Pipeline Products by Regulatory Path 15
Table 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 16
Table 6: Tissue Sealants - Ongoing Clinical Trials 17
Table 7: Tissue Sealants Companies - Pipeline Products by Stage of Development 18
Table 8: Tissue Sealants - Pipeline Products by Stage of Development 20
Table 9: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 10: LiquiBand - Product Status 22
Table 11: LiquiBand - Product Description 23
Table 12: Next Generation Internal Fixation And Sealant Device - Product Status 23
Table 13: Next Generation Internal Fixation And Sealant Device - Product Description 23
Table 14: Argon Medical Devices Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 15: Hemaseel HMN Fibrin Sealant - Product Status 24
Table 16: Hemaseel HMN Fibrin Sealant - Product Description 24
Table 17: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 18: Tisseel Dura - Product Status 25
Table 19: Tisseel Dura - Product Description 26
Table 20: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 27
Table 21: ClotBlock - Product Status 27
Table 22: ClotBlock - Product Description 27
Table 23: Boston University Pipeline Products & Ongoing Clinical Trials Overview 28
Table 24: Hydrogel-based Aerosolized Sealant Dressing - Product Status 28
Table 25: Hydrogel-based Aerosolized Sealant Dressing - Product Description 28
Table 26: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 27: Progel Dural Sealant - Product Status 29
Table 28: Progel Dural Sealant - Product Description 30
Table 29: Progel Emerald - Product Status 30
Table 30: Progel Emerald - Product Description 30
Table 31: Tridyne Aortic - Product Status 31
Table 32: Tridyne Aortic - Product Description 31
Table 33: Tridyne Peripheral - Product Status 32
Table 34: Tridyne Peripheral - Product Description 32
Table 35: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 36: Wound Sealant - Product Status 33
Table 37: Wound Sealant - Product Description 34
Table 38: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 35
Table 39: Surgical Adhesive Hydrogel - Product Status 35
Table 40: Surgical Adhesive Hydrogel - Product Description 35
Table 41: Cohera Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 42: Adhesive - Drug Delivery - Product Status 36
Table 43: Adhesive - Drug Delivery - Product Description 36
Table 44: Adhesive - Hernia Mesh Fixation - Product Status 37
Table 45: Adhesive - Hernia Mesh Fixation - Product Description 37
Table 46: Adhesive - Orthopedic Procedures - Product Status 37
Table 47: Adhesive - Orthopedic Procedures - Product Description 38
Table 48: Sylys Surgical Sealant - Product Status 38
Table 49: Sylys Surgical Sealant - Product Description 38
Table 50: Cohera Medical, Inc. - Ongoing Clinical Trials Overview 39
Table 51: Sylys Surgical Sealant - A Pilot, Prospective, Randomized, Controlled, Multicenter Technical Feasibility Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant 40
Table 52: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41
Table 53: Covabond - Product Status 41
Table 54: Covabond - Product Description 41
Table 55: DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 56: Dural Membrane Sealant - Product Status 42
Table 57: Dural Membrane Sealant - Product Description 42
Table 58: Emory University Pipeline Products & Ongoing Clinical Trials Overview 43
Table 59: Steroidal Hemostatic Surgical Adhesive - Product Status 43
Table 60: Steroidal Hemostatic Surgical Adhesive - Product Description 43
Table 61: Ethicon Endo-Surgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
Table 62: Bioseal Next Gen Device - Product Status 44
Table 63: Bioseal Next Gen Device - Product Description 44
Table 64: Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 65: GammaSeal - Product Status 45
Table 66: GammaSeal - Product Description 45
Table 67: Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview 46
Table 68: Bio-Inspired Surgical Liquid Film - Product Status 46
Table 69: Bio-Inspired Surgical Liquid Film - Product Description 46
Table 70: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 47
Table 71: Fibrin Biological Glue - Product Status 47
Table 72: Fibrin Biological Glue - Product Description 48
Table 73: Hemostasis, LLC Pipeline Products & Ongoing Clinical Trials Overview 49
Table 74: Advanced Tissue Sealant - Product Status 49
Table 75: Advanced Tissue Sealant - Product Description 49
Table 76: Bioabsorbable Bone Sealant - Product Status 50
Table 77: Bioabsorbable Bone Sealant - Product Description 50
Table 78: HyperBranch Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
Table 79: Adherus Vascular Sealant - Product Status 51
Table 80: Adherus Vascular Sealant - Product Description 51
Table 81: Tissue Plane Sealant - Product Status 52
Table 82: Tissue Plane Sealant - Product Description 52
Table 83: InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview 53
Table 84: InVivoSeal - Product Status 53
Table 85: InVivoSeal - Product Description 53
Table 86: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 54
Table 87: Chondroitin Sulfate-based Adhesive - Product Status 54
Table 88: Chondroitin Sulfate-based Adhesive - Product Description 54
Table 89: Kollodis BioSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 90: Hemostat Sealant - Product Status 55
Table 91: Hemostat Sealant - Product Description 55
Table 92: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 56
Table 93: KUR - 023 - Product Status 56
Table 94: KUR - 023 - Product Description 57
Table 95: KUR - 212 - Product Status 57
Table 96: KUR - 212 - Product Description 57
Table 97: LifeBond Ltd. Pipeline Products & Ongoing Clinical Trials Overview 58
Table 98: LifeSeal Surgical Sealant - Product Status 58
Table 99: LifeSeal Surgical Sealant - Product Description 59
Table 100: Tissue Adhesive - Product Status 59
Table 101: Tissue Adhesive - Product Description 59
Table 102: LifeBond Ltd. - Ongoing Clinical Trials Overview 60
Table 103: LifeSeal Surgical Sealant - Efficacy and Safety of LifeSeal Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses - A Prospective Randomized Study 61
Table 104: LifeSeal Surgical Sealant - Observational, Retrospective and Prospective, One Arm, Registry Study for the Effectiveness of LifeSeal Kit on Anastomotic Leaks in Patients Undergoing Low and Ultralow Anterior Resection (SEAL Registry) 61
Table 105: Medical Adhesive Revolution GmbH Pipeline Products & Ongoing Clinical Trials Overview 62
Table 106: CUTIS - Product Status 62
Table 107: CUTIS - Product Description 62
Table 108: VIVO - Product Status 63
Table 109: VIVO - Product Description 63
Table 110: Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 64
Table 111: PTMC Sealant - Product Status 64
Table 112: PTMC Sealant - Product Description 64
Table 113: OptMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
Table 114: Biosurgical Adhesive - Chronic Wounds - Product Status 65
Table 115: Biosurgical Adhesive - Chronic Wounds - Product Description 65
Table 116: Biosurgical Adhesive - Internal Use - Product Status 66
Table 117: Biosurgical Adhesive - Internal Use - Product Description 66
Table 118: Biosurgical Adhesive - Skin Tears - Product Status 66
Table 119: Biosurgical Adhesive - Skin Tears - Product Description 67
Table 120: Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview 68
Table 121: Recombinant Fibrin Tissue Sealant - Product Status 68
Table 122: Recombinant Fibrin Tissue Sealant - Product Description 69
Table 123: Polyganics B.V. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 124: Dura Sealant Device - Product Status 70
Table 125: Dura Sealant Device - Product Description 70
Table 126: Liver Sealant Device - Product Status 71
Table 127: Liver Sealant Device - Product Description 71
Table 128: Polyganics B.V. - Ongoing Clinical Trials Overview 72
Table 129: Dura Sealant Device - A Randomized Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated (FS VH S/D 500 S-apr) Compared to DuraSeal Dural Sealant as an Adjunct to Sutured Dural Repair in Cranial Surgery 73
Table 130: Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74
Table 131: Surgical Tissue Sealant - Product Status 74
Table 132: Surgical Tissue Sealant - Product Description 74
Table 133: Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 75
Table 134: SEA-STAT CNS - Product Status 75
Table 135: SEA-STAT CNS - Product Description 75
Table 136: Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76
Table 137: Seal-G - Product Status 76
Table 138: Seal-G - Product Description 76
Table 139: Seal-V - Product Status 77
Table 140: Seal-V - Product Description 77
Table 141: Sealantis Tissue Adhesive - Product Status 77
Table 142: Sealantis Tissue Adhesive - Product Description 78
Table 143: Sealantis Ltd. - Ongoing Clinical Trials Overview 79
Table 144: Seal-G - A Prospective, Multi-center, Open Label, Non-randomized Study, of Seal-G Surgical Sealant for the Reinforcement of Gastrointestinal Anastomosis 80
Table 145: Shanghai Haohai Biological Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
Table 146: Fibrinsealant - Product Status 81
Table 147: Fibrinsealant - Product Description 81
Table 148: Fibrinsealant Powder - Product Status 82
Table 149: Fibrinsealant Powder - Product Description 82
Table 150: Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
Table 151: Thorex - Product Status 83
Table 152: Thorex - Product Description 83
Table 153: Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 84
Table 154: KTF-374 Fibrin Sealant - Product Status 84
Table 155: KTF-374 Fibrin Sealant - Product Description 85
Table 156: Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 86
Table 157: Tissue Welding Device - Product Status 86
Table 158: Tissue Welding Device - Product Description 87
Table 159: Wound Healing and Tissue Repair Bandage - Product Status 87
Table 160: Wound Healing and Tissue Repair Bandage - Product Description 87
Table 161: The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview 88
Table 162: Prevent GI Sealant - Product Status 88
Table 163: Prevent GI Sealant - Product Description 89
Table 164: University of Akron Pipeline Products & Ongoing Clinical Trials Overview 90
Table 165: Wound Closure Glue - Product Status 90
Table 166: Wound Closure Glue - Product Description 90
Table 167: Glossary 153

List Of Figures
1.2 List of Figures
Figure 1: Tissue Sealants - Pipeline Products by Stage of Development 12
Figure 2: Tissue Sealants - Pipeline Products by Segment 13
Figure 3: Tissue Sealants - Pipeline Products by Territory 14
Figure 4: Tissue Sealants - Pipeline Products by Regulatory Path 15
Figure 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 16
Figure 6: Tissue Sealants - Ongoing Clinical Trials 17

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.